Pharmaceutical Technology

JUNE 6, 2025

The approval process for cell and gene therapy candidates is tricky, however, given their high-cost and oft-debated benefit-risk ratio. RFK Jr did not question their importance, and acknowledged panellists’ calls for faster regulatory processes. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

Insurance Coverage and Processing 81

Insurance Coverage and Processing Communication Hospitals Drug Development 81

Pharmaceutical Technology

JUNE 12, 2025

Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. In 2023, SpliceBio signed a licensing agreement with Spark Therapeutics, allowing the latter to use its protein splicing platform and develop a gene therapy for an undisclosed inherited renal disease.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Communication Hospitals Packaging 52

Pharmaceutical Technology

FEBRUARY 7, 2023

Launching a new drug can be a risky business, with regulatory approval no guarantee that private, commercial, and government-funded insurers will reimburse it. Meanwhile, in Germany, the AMNOG process is conducted twelve months after the drug is launched, thus giving freedom to the company to set the drug’s price during this period.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Inpatient Drug Pricing Packaging 52

Pharmaceutical Technology

JUNE 16, 2025

These platforms are designed for safe drug production while allowing scaleable manufacturing processes. mRNA vaccine coverage on Pharmaceutical Technology (or Clinical Trials Arena) is supported by Trilink. The trial data indicated dose-dependent protein production at the site without systemic bioavailability. “By

Insurance Coverage and Processing 52

Insurance Coverage and Processing Vaccines Communication Hospitals 52

Pharmaceutical Technology

JUNE 16, 2025

Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Editorial content is independently produced and follows the highest standards of journalistic integrity. Topic sponsors are not involved in the creation of editorial content. Give your business an edge with our leading industry insights.

Insurance Coverage and Processing 98

Insurance Coverage and Processing Communication Hospitals Vaccines 98

Pharmaceutical Technology

JUNE 13, 2025

mRNA vaccine coverage on Pharmaceutical Technology (or Clinical Trials Arena) is supported by Trilink. GSK also has an FDA-approved vaccine in the form of Arexvy, though its label only covers those at risk in individuals aged between 50 through 59 years , along with the standard indication of ages 60 and over.

Vaccines 52

Vaccines Insurance Coverage and Processing Labelling Communication 52

Pharmaceutical Technology

JUNE 10, 2025

Disrupting ACIP’s work introduces dangerous uncertainty about which vaccines will continue to be covered and whether families will have to pay out of pocket for routine immunisations,” the non-profit said. Give your business an edge with our leading industry insights.

Vaccines 52

Vaccines Insurance Coverage and Processing Drug Pricing Immunity 52